127 related articles for article (PubMed ID: 2921356)
21. Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study.
Boman F; Buisine MP; Wacrenier A; Querleu D; Aubert JP; Porchet N
J Pathol; 2001 Mar; 193(3):339-44. PubMed ID: 11241413
[TBL] [Abstract][Full Text] [Related]
22. Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.
Curling M; Stenning S; Hudson CN; Watson JV
J Clin Pathol; 1998 Jun; 51(6):455-61. PubMed ID: 9771445
[TBL] [Abstract][Full Text] [Related]
23. [Distribution and diagnostic role of COTA in mucinous ovarian tumors].
Shi ZL
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):191-2. PubMed ID: 2612330
[TBL] [Abstract][Full Text] [Related]
24. Oncogene expression in ovarian cancer: a pilot study of c-myc oncoprotein in serous papillary ovarian cancer.
Watson JV; Curling OM; Munn CF; Hudson CN
Gynecol Oncol; 1987 Oct; 28(2):137-50. PubMed ID: 3311922
[TBL] [Abstract][Full Text] [Related]
25. [A study of amplifications of myc gene (c-myc and N-myc) in human ovarian cancer].
Kataoka A; Yakushiji M; Kojiro M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):259-63. PubMed ID: 2332674
[TBL] [Abstract][Full Text] [Related]
26. Expression of metallothionein and nuclear size in discrimination of malignancy in mucinous ovarian tumors.
Tan Y; Sinniah R; Bay BH; Singh G
Int J Gynecol Pathol; 1999 Oct; 18(4):344-50. PubMed ID: 10542943
[TBL] [Abstract][Full Text] [Related]
27. C-myc oncogene expression in anal squamous neoplasia.
Ogunbiyi OA; Scholefield JH; Rogers K; Sharp F; Smith JH; Polacarz SV
J Clin Pathol; 1993 Jan; 46(1):23-7. PubMed ID: 7679417
[TBL] [Abstract][Full Text] [Related]
28. Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors.
Sugai M; Umezu H; Yamamoto T; Jiang S; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2008 Nov; 58(11):681-6. PubMed ID: 18844932
[TBL] [Abstract][Full Text] [Related]
29. Nuclear morphometry and AgNOR quantification: computerized image analysis on ovarian mucinous tumor imprints.
Versa-Ostojić D; Stanković T; Stemberger-Papić S; Vrdoljak-Mozetic D; Manestar M; Krasević M
Anal Quant Cytol Histol; 2008 Jun; 30(3):160-8. PubMed ID: 18630841
[TBL] [Abstract][Full Text] [Related]
30. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.
Mok SC; Bell DA; Knapp RC; Fishbaugh PM; Welch WR; Muto MG; Berkowitz RS; Tsao SW
Cancer Res; 1993 Apr; 53(7):1489-92. PubMed ID: 8384077
[TBL] [Abstract][Full Text] [Related]
31. C-myc oncogene expression in ocular melanomas.
Royds JA; Sharrard RM; Parsons MA; Lawry J; Rees R; Cottam D; Wagner B; Rennie IG
Graefes Arch Clin Exp Ophthalmol; 1992; 230(4):366-71. PubMed ID: 1505770
[TBL] [Abstract][Full Text] [Related]
32. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
Evans MF; McDicken IW; Herrington CS
J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
[TBL] [Abstract][Full Text] [Related]
33. In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.
Sieben NL; Macropoulos P; Roemen GM; Kolkman-Uljee SM; Jan Fleuren G; Houmadi R; Diss T; Warren B; Al Adnani M; De Goeij AP; Krausz T; Flanagan AM
J Pathol; 2004 Mar; 202(3):336-40. PubMed ID: 14991899
[TBL] [Abstract][Full Text] [Related]
34. Chromosomal analysis in malignant ovarian tumors.
Sonwalker AA; Grover S
Am J Obstet Gynecol; 1974 Apr; 118(7):961-5. PubMed ID: 4361960
[No Abstract] [Full Text] [Related]
35. Histological discrimination of malignancy in mucinous ovarian tumours.
Blanco AA; Gibbs AC; Langley FA
Histopathology; 1977 Nov; 1(6):431-43. PubMed ID: 210104
[TBL] [Abstract][Full Text] [Related]
36. [Overexpression of c-erbB-2 oncogene in primary ovarian cancers: incidence and prognostic significance in 243 patients].
Meden H; Marx D; Rath W; Kuhn W; Hinney B; Schauer A
Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):667-73. PubMed ID: 1360438
[TBL] [Abstract][Full Text] [Related]
37. Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours.
Hynninen P; Vaskivuo L; Saarnio J; Haapasalo H; Kivelä J; Pastoreková S; Pastorek J; Waheed A; Sly WS; Puistola U; Parkkila S
Histopathology; 2006 Dec; 49(6):594-602. PubMed ID: 17163844
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneous genetic alterations in ovarian mucinous tumors: application and usefulness of laser capture microdissection.
Takeshima Y; Amatya VJ; Daimaru Y; Nakayori F; Nakano T; Inai K
Hum Pathol; 2001 Nov; 32(11):1203-8. PubMed ID: 11727259
[TBL] [Abstract][Full Text] [Related]
39. A huge ovarian mucinous cystadenoma in a 14-year-old premenarchal girl: review on ovarian mucinous tumor in premenarchal girls.
Karaman A; Azili MN; Boduroğlu EC; Karaman I; Erdoğan D; Cavuşoğlu YH; Aslan MK; Cakmak O
J Pediatr Adolesc Gynecol; 2008 Feb; 21(1):41-4. PubMed ID: 18312801
[TBL] [Abstract][Full Text] [Related]
40. Ovarian mucinous cystadenoma of borderline malignancy in a premenarchal girl.
Iwasaki M; Taira K; Kobayashi H; Saiga T
J Pediatr Adolesc Gynecol; 2010 Jun; 23(3):e119-23. PubMed ID: 19896401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]